<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20221030056342N3</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2024-10-24</date_registration>
      <primary_sponsor>Mashhad University of Medical Sciences</primary_sponsor>
      <public_title>The effect of physical therapy combined with dry needling compared to physical therapy alone on hand muscle strength in people with carpal tunnel syndrome</public_title>
      <acronym></acronym>
      <scientific_title>Investigating the effect of physical therapy combined with dry needling compared to physical therapy alone on hand muscle strength in people with carpal tunnel syndrome: a randomized clinical trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2024-12-02</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>34</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/79296</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: In the present study, the quadruple randomization block method will be used for randomization. For this method, the volume of each block must be determined first (for example, a quadruple block). Then write the list of blocks and assign numbers to them (AABB(1)- ABAB(2)-ABBA(3)-BBAA(4)- BABA(5)- BAAB(6)) then choose random numbers between 1 and 6 (for example, 1, 4, 5, etc.) and finally specifying the treatment allocation list based on the previous random numbers (...AABB-BBAA-BABA-).}. The website www.sealedenvelope.com will be used to generate the assigned sequences, Blinding description: Patients are randomly assigned to two groups of physical therapy alone (control group) and physical therapy with dry needling (treatment group) by the method of quadruple random blocks by a person who is not involved in any of the intervention and evaluation stages.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Carpal tunnel syndrome.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: In the treatment group, in addition to the standard rehabilitation program that is also performed in the control group, dry needling will be applied in the wrist region based on the Four Pole Carpal Dry Needling technique by the physiotherapist. In this method, needles with dimensions of 25*0.30 mm are placed in their position in all patients according to anatomical references. The highest needles are at the scaphoid (proximal-radial: P-R) and pisiform (proximal-ulnar: P-U) bones, while the lowest ones are at the level of the trapezium (distal-radial: D-R) and hamate (distal-ulnar: D-U) bones. ) are placed. 4 oblique directional needles (45 degrees in both cranio-caudal and internal-external directions), slightly inclined to the back and at the same time follow the midline. Each needle is inserted into the tissue until an elastic state is felt, which in the absence of ultrasound confirmation is attributed to the transverse carpal ligament. Fascial winding technique (FWT) is then applied to each needle, which involves twisting them in one direction until reaching the final threshold of "Needle grasp". The rotation of the needles is limited due to their adhesion to the tissue, which means that by applying force to remove the needles, the tissue will be exposed to tension. This force is along the longitudinal axis of the needles, but it is not enough to pull them out of the tissue and it must be done simultaneously on each pair of opposite needles that are two by two miles together (i.e. P-R with D-U and P-U with D-R). At this moment, we consider the FWT complete. This method leads to continuous tension on the transverse carpal ligament, which is stronger and more effective. In the treatment group, dry needling will be performed at the beginning of the first, fifth and ninth sessions before routine physiotherapy, and patients will be advised to refrain from taking NSAIDs 24 hours before and after the dry needling treatment. Intervention 2: Control group: In the control group, the standard rehabilitation program includes electrotherapy, ultrasound modality, median nerve mobilization techniques and gliding flexor tendons, and exercises that will be placed in the form of brochures to be performed at the patient's home. The mobilization technique of the median nerve, which is performed by the physiotherapist, and the gliding of the flexor tendons will be explained in detail, and the patient will be taught how to do the exercise at home. The treatment duration of the standard rehabilitation program is 45 to 60 minutes per session. And it is as follows: 20 minutes of electrotherapy in the form of tennis with a frequency of 80 Hz and a pulse width of 60 microseconds - 5 minutes of interrupted ultrasound on the carpal tunnel area of ​​the wrist with a frequency of 1 MHz and an intensity of 1 watt per square centimeter - mobilization of the median nerve in 3 sets with 15 repetitions in Each session - Glide the flexor tendons of the hand so that each exercise is repeated 1 to 3 times for 10 times and each position is maintained for 5 seconds. Teaching exercises to stretch the transverse carpal ligament and glide the median nerve and flexor tendons to be done at home as follows: 1) Stretching the transverse carpal ligament by the patient: the patient is asked to bend his wrist upwards at a 90 degree angle. and connect his palm to the opposite wall, and with his opposite hand, slowly pull the thenar ridge towards him so that the transverse carpal ligament is stretched. Participants are asked to hold each stretch for 30 seconds and do it 4 times a day during their treatment period. Participants in this study will be treated for 12 sessions, 3 sessions per week.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All data will be reported in the form of a research article. Raw data will be delivered to researchers for meta analysis.

When:
6 months after publication

To whom:
For researchers only

Conditions:
For meta-analysis Only

Where to obtain:
zeinalzadehAF@mums.ac.ir

How to obtain:
The response will be sent 3 within months after considering the researcher's request.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Shayeste Jan Alizadeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Paramedical and Rehabilitation Sciences, Kharazmi Building, University Campus, East Door of Mashhad University of Medical Sciences, Azadi Square</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9177948964</zip>
        <telephone>+98 51 3884 6710</telephone>
        <email>Janalizadehs4002@mums.ac.ir</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Afsaneh Zeinalzadeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Faculty of Paramedical and Rehabilitation Sciences, Kharazmi Building, University Campus, East Door of Mashhad University of Medical Sciences, Azadi Square</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9177948964</zip>
        <telephone>+98 51 3884 6710</telephone>
        <email>zeinalzadehAF@mums.ac.ir</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Clinical diagnosis of CTS based on at least two criteria proposed by Chang
Presence of symptoms for at least 4 weeks
Confirmation of mild to moderate severity of CTS based on electrodiagnostic findings</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Clinical conditions that can mimic CTS include cervical radiculopathy, brachial plexus injury, proximal median neuropathy, or significant polyneuropathy.
Severe CTS with visible muscle atrophy
Diabetes
Rheumatoid arthritis
Hypothyroidism and hyperthyroidism
Pregnancy and breastfeeding
Alcohol abuse
Taking medicine
Malignancy</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G56.0</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Carpal tunnel syndrome</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: In the treatment group, in addition to the standard rehabilitation program that is also performed in the control group, dry needling will be applied in the wrist region based on the Four Pole Carpal Dry Needling technique by the physiotherapist. In this method, needles with dimensions of 25*0.30 mm are placed in their position in all patients according to anatomical references. The highest needles are at the scaphoid (proximal-radial: P-R) and pisiform (proximal-ulnar: P-U) bones, while the lowest ones are at the level of the trapezium (distal-radial: D-R) and hamate (distal-ulnar: D-U) bones. ) are placed. 4 oblique directional needles (45 degrees in both cranio-caudal and internal-external directions), slightly inclined to the back and at the same time follow the midline. Each needle is inserted into the tissue until an elastic state is felt, which in the absence of ultrasound confirmation is attributed to the transverse carpal ligament. Fascial winding technique (FWT) is then applied to each needle, which involves twisting them in one direction until reaching the final threshold of "Needle grasp". The rotation of the needles is limited due to their adhesion to the tissue, which means that by applying force to remove the needles, the tissue will be exposed to tension. This force is along the longitudinal axis of the needles, but it is not enough to pull them out of the tissue and it must be done simultaneously on each pair of opposite needles that are two by two miles together (i.e. P-R with D-U and P-U with D-R). At this moment, we consider the FWT complete. This method leads to continuous tension on the transverse carpal ligament, which is stronger and more effective. In the treatment group, dry needling will be performed at the beginning of the first, fifth and ninth sessions before routine physiotherapy, and patients will be advised to refrain from taking NSAIDs 24 hours before and after the dry needling treatment.</i_keyword>
      <i_keyword>Control group: In the control group, the standard rehabilitation program includes electrotherapy, ultrasound modality, median nerve mobilization techniques and gliding flexor tendons, and exercises that will be placed in the form of brochures to be performed at the patient's home. The mobilization technique of the median nerve, which is performed by the physiotherapist, and the gliding of the flexor tendons will be explained in detail, and the patient will be taught how to do the exercise at home. The treatment duration of the standard rehabilitation program is 45 to 60 minutes per session. And it is as follows: 20 minutes of electrotherapy in the form of tennis with a frequency of 80 Hz and a pulse width of 60 microseconds - 5 minutes of interrupted ultrasound on the carpal tunnel area of ​​the wrist with a frequency of 1 MHz and an intensity of 1 watt per square centimeter - mobilization of the median nerve in 3 sets with 15 repetitions in Each session - Glide the flexor tendons of the hand so that each exercise is repeated 1 to 3 times for 10 times and each position is maintained for 5 seconds. Teaching exercises to stretch the transverse carpal ligament and glide the median nerve and flexor tendons to be done at home as follows: 1) Stretching the transverse carpal ligament by the patient: the patient is asked to bend his wrist upwards at a 90 degree angle. and connect his palm to the opposite wall, and with his opposite hand, slowly pull the thenar ridge towards him so that the transverse carpal ligament is stretched. Participants are asked to hold each stretch for 30 seconds and do it 4 times a day during their treatment period. Participants in this study will be treated for 12 sessions, 3 sessions per week.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Hand grip. Timepoint: Before, immediately after and six weeks after the end of treatment. Method of measurement: Grip strength will be measured in kilograms using a hand-held dynamometer. First, patients are taught how to work with the device. They are then asked to maintain maximum grip strength and press the handle 3 times with 10 seconds of rest between each test, and the average score of the three presses of the machine will be calculated.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Pain severity. Timepoint: Before, immediately after and six weeks after completion. Method of measurement: Visual analog scale (VAS) will be used to evaluate pain intensity at rest (8). VAS is a 10-point scale from 0 to 10, where 0 represents "no pain" and 10 represents "worst possible pain". All participants are instructed to rate pain intensity based on the past 7 days.</sec_outcome>
      <sec_outcome>Functional status and symptom severity. Timepoint: Before, immediately after and six weeks after completion. Method of measurement: Functional status and severity of self-reported symptoms will be measured using the self-reported Boston Carpal Tunnel Questionnaire (BCTQ). This is a CTS-specific questionnaire that refers to a typical 24-hour period in the past two weeks. It consists of two different scales: Symptom Severity Scale (SSS) and Functional Status Scale (FSS). The SSS consists of 11 questions about symptom severity, while the FSS consists of 8 daily activities that are rated by severity. These two scales will be rated on a 5-point scale, where greater impairment is indicated by higher scores, and finally, the average of each section is calculated, and the higher the average, the greater the severity of the patient's symptoms and disability. The BCTQ is responsive to clinically relevant changes and is therefore an appropriate measure of treatment outcome. This questionnaire was Persianized by Mashhad University of Medical Sciences and its reliability and validity have been reported before.</sec_outcome>
      <sec_outcome>The effectiveness of treatment. Timepoint: Before, immediately after and six weeks after completion. Method of measurement: Global rating of change (GRC) will be used to evaluate the effectiveness of the treatment, which evaluates the patient's current health status compared to the patient's status at the beginning of the treatment. It is an 11-point Likert scale ranging from +5 (much better) to -5 (much worse).</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Mashhad University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2024-02-24</approval_date>
        <contact_name>Ethics Committee of Mashhad University of Medical Sciences</contact_name>
        <contact_address>Central Organization of Mashhad University of Medical Sciences, Knowledge and Health City, End of Shahid Fakuri Blvd. Mashhad Razavi Khorasan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
